daboost / iStockphoto.com
Chosun University in Korea has taken on EMD Millipore, a life sciences subsidiary of Merck, in a patent infringement claim centring on derivatives of thiazolidinedione.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Chosun University, EMD Millipore, patent, patent infringement, chemicals, life sciences, Merck Millipore